info@seagull-health.com
SeagullHealth
语言:
search
new
What Are the Indications of Dimemorfan Phosphate Tablets (Astomin)?
503
Article source: Seagull Pharmacy
Nov 14, 2025

Dimemorfan Phosphate Tablets (Astomin) are non-narcotic central antitussives. Owing to their low side effects and low addictiveness, they exhibit unique value in clinical practice.

What Are the Indications of Dimemorfan Phosphate Tablets (Astomin)?

Primary Indications

Dimemorfan Phosphate Tablets are mainly indicated for the control of cough symptoms in patients aged 15 years and above, especially for coughs caused by acute and chronic respiratory diseases.

Its mechanism of action is to inhibit the medullary cough center and block the cough reflex pathway, thereby relieving symptoms quickly.

Precautions

At present, this drug has not been marketed in Mainland China, nor has it been included in the medical insurance catalog, and there are no generic drugs available on the market.

Pregnant women need to weigh the therapeutic benefits against the risks.

Lactating women should comprehensively assess the pros and cons of taking the drug versus breastfeeding.

Elderly patients need to use a reduced dose due to the decline in physiological functions.

The efficacy of this drug in children has not been clearly specified in the package insert.

Specifications and Characteristics of Dimemorfan Phosphate Tablets (Astomin)

Formulation Features

Dimemorfan Phosphate Tablets are white sugar-coated tablets, with a round shape, a diameter of 6.9 mm, a thickness of 3.4 mm, and a single tablet weight of 140 mg.

The surface of the tablet is engraved with the identification code "アストミン" (the Japanese mark for "Astomin"), which facilitates the verification of the authenticity of the drug.

Each tablet contains the main ingredient Dimemorfan Phosphate, with a dosage of 10 mg per tablet (calculated as dimemorfan phosphate).

In terms of dosage form design, this drug is packaged in PTP (Press-Through Package) aluminum foil. It is particularly important to note that the tablet must be taken out of the aluminum foil before administration to avoid accidental ingestion of the packaging material, which may lead to severe complications such as esophageal mucosal injury or even perforation.

Storage Conditions of Dimemorfan Phosphate Tablets (Astomin)

Storage Environment

Dimemorfan Phosphate Tablets should be stored at room temperature, away from direct sunlight and humid environments.

The shelf life of the drug is marked as 36 months, and the production date should be checked when using it.

It is particularly important to remind that if the drug is packaged in PTP aluminum foil, patients must be instructed to take the tablet out of the aluminum foil before taking it to prevent accidental ingestion of the packaging material and subsequent esophageal mucosal injury.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
What Are the Side Effects of Enasidenib?
Enasidenib is a targeted medication for isocitrate dehydrogenase-2 (IDH2) mutations, indicated for adult patients with relapsed or refractory acute myeloid leukemia (AML). As a prescription-only drug,...
What are the Precautions for Taking Enasidenib?
Enasidenib is an isocitrate dehydrogenase-2 (IDH2) inhibitor that provides a targeted treatment option for patients with relapsed or refractory acute myeloid leukemia (AML).What are the Precautions fo...
Dosage and Administration of Enasidenib
Enasidenib is an isocitrate dehydrogenase-2 (IDH2) inhibitor approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or refractory acute myeloid leuke...
Indications for Enasidenib
Enasidenib is an isocitrate dehydrogenase-2 (IDH2) inhibitor indicated for the treatment of relapsed or refractory acute myeloid leukemia (AML) with specific gene mutation types.Indications for Enasid...
What Are the Precautions for Taking Dimemorfan Phosphate Tablets (Astomin)?
Dimemorfan Phosphate Tablets (Astomin) are a type of non-narcotic central antitussive. Since its first approval in Japan in 1975, it has been widely used to relieve cough symptoms in adults due to its...
Procurement Channels for Epalrestat
Epalrestat is an aldose reductase inhibitor that was first approved in Japan in 1992. It is mainly used for the treatment of diabetic peripheral neuropathy. Its mechanism of action involves inhibiting...
What Are the Indications of Epalrestat?
Epalrestat is an aldose reductase inhibitor that holds an important position in the treatment of diabetic complications. Since its first approval in Japan in 1992, it has become one of the key medicat...
Dosage and Administration of Epalrestat: Recommended Dosage
Epalrestat is a selective aldose reductase inhibitor. Since its approval in Japan in 1992, it has become an important therapeutic agent for diabetic peripheral neuropathy.Dosage and Administration of ...
Related Articles
Dosage and Administration, Recommended Dosage of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a highly selective MET inhibitor, offering a precision treatment option for patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutation...
What Are the Indications for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a targeted therapy medication that plays an important role in the treatment of non-small cell lung cancer associated with specific gene mutations. As a MET kinase inhibitor, i...
What Are the Purchase Channels for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a highly selective MET inhibitor that has demonstrated significant efficacy in patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutat...
Adverse Reactions of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is an isocitrate dehydrogenase 1 (IDH1) inhibitor, primarily indicated for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and cholangiocarcinoma...
What Are the Precautions for Using Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is a targeted therapy medication primarily indicated for the treatment of patients with malignant hematologic diseases harboring specific gene mutations.What Are the Precautions f...
Dosage and Administration, Recommended Dosage of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is a targeted isocitrate dehydrogenase 1 (IDH1) inhibitor that demonstrates significant value in the treatment of malignant tumors with specific gene mutations.Dosage and Administ...
What Are the Indications for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an oral isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for patients with various malignant tumors harboring specific IDH1 gene mutations. By inhibiting the activity of m...
What Are the Purchase Channels for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an important targeted therapy drug against IDH1 mutations, demonstrating significant efficacy in diseases such as acute myeloid leukemia and cholangiocarcinoma. For patients in...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved